Neuroendocrine tumor (NET) expert, Lowell Anthony, MD, answers questions neuroendocrine cancer patients have about the COVID-19 pandemic. Questions include: Does immunotherapy offer any protection against COVID19?
Dr. Lowell Anthony is Chief of the Division of Medical Oncology at the UK Markey Cancer Center in Lexington, Kentucky. His clinical interests include drug development ranging from Phase I to III clinical trials. Agents targeting specific cellular signaling pathways and injectable radiolabeled compounds make up his past and current clinical investigative interests.
For more information about neuroendocrine cancer, visit our website:
For more information about Dr. Lowell Anthony, follow this link:
